Shots: Puma to receive upfront, milestones up to $7.2M and royalties on sales in Canada. Knight to get exclusive commercialization rights for Nerlynx and will also be responsible for its […]readmore
Tags : Agreement
Shots: Samsung to receive upfront, milestone and royalties on sales. 3SBio to get development & commercialization rights for Samsung’s biosimilars including SB8 (bevacizumab, Avastin) in China The focus of the […]readmore
Shots: Esperion to receive $150M upfront, $150M sales milestones and up to $900M regulatory milestones including royalties. Daiichi to get exclusive commercialization rights for Esperion’s bempedoic acid and bempedoic acid […]readmore
Shots: Curium to get exclusive license to develop and commercialize PyL in EU and Progenics to get royalties on the net sales The focus of the agreement is to advance […]readmore
Shots: Molecular to receive $50M upfront, $497M milestone and royalties on sales and also has certain rights to commercialize DARPin based products with MP0310. Amgen to get exclusive worldwide development and commercialization rights […]readmore
Shots: Domain to receive upfront, milestones, and royalties on sales from Boehringer Ingelheim The focus of the agreement is to discover & develop GPCRs, using Domain’s DTect-All and bioSens-All technology […]readmore
Shots: The collaboration is focused on development of Larazotide for Alcoholic Liver Diseases (ALD), including severe alcoholic hepatitis Innovate will conduct an investor update on 17 Dec, 2018 for Larazotide, […]readmore
Shots: Cilag (subsidiary of Janssen) to get worldwide commercialization rights for Cusatuzumab, with an option for Argenx to take part in the US activities. Argenx to receive $300M upfront, $200M equity […]readmore
Shots: Pfizer to get worldwide IPR for Humira in the US and other countries and will pay royalties on sales to AbbVie Humira’s the US license right will begin from […]readmore
Shots: Beigene to get exclusive development and commercialization rights to ZW’s ZW25 and ZW49 candidates in Asia, New Zealand and Australia (ex. Japan). ZW to receive $40M upfront, $390M milestones […]readmore